Pharmaceutical Technology Europe
Millions of pounds worth of products are at risk if contamination occurs in a cleanroom environment. According to an independent consultant (Cleanroom Management Associates Inc) for our company, contamination from personnel and equipment, such as wheeled carts and tanks, is a major concern in cleanrooms and controlled environments.
Millions of pounds worth of products are at risk if contamination occurs in a cleanroom environment. According to an independent consultant (Cleanroom Management Associates Inc) for our company, contamination from personnel and equipment, such as wheeled carts and tanks, is a major concern in cleanrooms and controlled environments.
Mark Dalziel. Managing director at Dycem Ltd
The consequences of contamination are severe. A single microbe in a batch of aseptic drugs could cause the entire batch to be quarantined or scrapped, leading to supply shortages, financial consequences, product recalls, FDA warning letters or even company shutdown in the worst case scenario.
High levels of air-borne contamination can lead to microbial corruption of cleanroom surfaces. By their very nature, the movement of airborne contaminants is volatile, which makes detection and prevention measures difficult. Contaminants are generated by people, process, facilities and equipment, and must be continually controlled and removed from the air.
Particles outside critical areas are a potential problem because they are not easily detectable, particularly small, light, invisible particles. Even loose particles that settle on the floor can be easily crushed into very small particles and redistributed back into the air due to vortices created by movement. These airborne particles become suspended in the air and get carried into the critical area where they present a potential hazard. Such particles are difficult to control because they are hard to see with the naked eye.
An effective contamination control regime should be put in place. ISO cleanroom standards recommend and cGMP necessitates that the introduction of particles into critical areas is minimised.
Effective contamination control requires a progressive zonal approach. Areas that are critical to maintaining cleanroom zones are entrances and exits; any areas used or inhabited by personnel, particularly gowning and staff changing areas and airlocks. Organisations also need to monitor and ensure that effective decontamination measures are in place in any areas where equipment, trolleys or tanks are moved.
All critical areas should also be sampled for particulates. Particles can be viable or non-viable, made from different materials, come from different places and travel large distances. There are two main types of contamination:
One of the most effective ways to minimise airborne contamination is to focus on the design of the cleanroom; all processes should be implemented with the reduction of airborne particles in mind.
Regulators and other professional bodies such as the International Society for Pharmaceutical Engineering (ISPE) recognise the importance of controlling contamination and implementing an effective contamination control flooring system. Flooring used in critical areas can be one of the most effective ways of reducing all contamination whether it’s foot, wheel or airborne, since the majority of contaminants enter the cleanroom at or near floor level. Unprotected flooring enables contaminants to be picked up on shoes and on the wheels of carts where they are tracked into the critical area. Here, there is a risk of them being redistributed back into the atmosphere.
Specialised flooring solutions can vastly reduce contamination risks. For example, polymeric flooring embeds particulates within its cellular structure, rather than binding it with surface adhesive as is done with peel-off mat flooring products. Peel-off mats have a surface area that is on average five times smaller than polymeric flooring, which doesn’t allow the three full wheel rotations necessary to decontaminate wheeled traffic. In addition, peel-off mats are also prone to wrapping around wheels of trolleys and carts making it impossible to control cross contamination in corridors.
In general, it’s important to consider the following:
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.